Premium
The U‐shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case–control study from eight East Asian cohort studies
Author(s) -
Jang Jieun,
Wang Tianyi,
Cai Hui,
Ye Fei,
Murphy Gwen,
Shimazu Taichi,
Taylor Philip R,
Qiao YouLin,
Yoo KeunYoung,
Jee Sun Ha,
Kim Jeongseon,
Chen SheauChiann,
Abnet Christian C,
Tsugane Shoichiro,
Zheng Wei,
Shu XiaoOu,
Pawlita Michael,
Park Sue K.,
Epplein Meira
Publication year - 2019
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.32790
Subject(s) - medicine , body mass index , nested case control study , odds ratio , cohort study , cohort , confidence interval , case control study , gastroenterology , helicobacter pylori , cancer
The association between body mass index (BMI) and noncardia gastric cancer (NCGC) risk remains controversial. The purpose of our study was to examine the association of BMI with NCGC risk with consideration of Helicobacter pylori (HP) biomarkers. This international nested case–control study, composed of 1,591 incident NCGC cases and 1,953 matched controls, was established from eight cohorts in China, Japan and Korea, where the majority of NCGCs are diagnosed worldwide. HP antibody biomarkers were measured in blood collected at cohort enrollment by multiplex serology. The NCGC risk according to baseline BMI was estimated using logistic regression to produce odds ratios (ORs) and 95% confidence intervals (CIs). We found a U‐shaped association between BMI category and NCGC risk. Compared to those with reference BMI (22.6–25.0 kg/m 2 ), those with lower and higher BMI had an increased NCGC risk (BMI <18.5 kg/m 2 , OR = 1.56, 95% CI = 1.04–2.34; BMI >27.5 kg/m 2 , OR = 1.48, 95% CI = 1.15–1.91; adjusted for age, sex and smoking). The U‐shaped association was persistent among subjects with HP infection and high‐risk biomarkers (HP+ CagA+: BMI <18.5 kg/m 2 , OR = 1.60, 95% CI = 1.00–2.55; BMI >27.5 kg/m 2 , OR = 1.59, 95% CI = 1.21–2.11; and Omp+ HP0305+: BMI <18.5 kg/m 2 , OR = 1.88, 95% CI = 1.04–3.42; BMI >27.5 kg/m 2 , OR = 1.70, 95% CI = 1.20–2.42, respectively). Our study provides evidence of significantly increased NCGC risk among individuals with low or high BMI, including in subjects with high‐risk HP biomarkers (HP+ CagA+, Omp+ HP0305+) in the high‐risk area of East Asia.